2019
DOI: 10.1080/13816810.2018.1561902
|View full text |Cite
|
Sign up to set email alerts
|

Novel mutations in the OPN1LW and NR2R3 genes in a patient with blue cone monochromacy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…In this study, we collected some mutations associated with color vision deficiencies (Figure 6 and Figure S8). The mutations identified within the LWS-opsin are K82 ICL1 E, N94 2.45 K, V120 ECL1 M, S143 3.42 P, W177 4.50 R, C203 ECL2 R, P231 5.50 L, R247 5.66 X, P307 7.38 L, R330 8.51 Q, and G338 8.59 E(Nathans et al, 1993; Ueyama et al, 2002; Carroll et al, 2004; Ueyama et al, 2004; Mizrahi-Meissonnier et al, 2010; Cai et al, 2019; Iarossi et al, 2021; Zhu et al, 2021) (Figures 6A and S8A). It is noteworthy that the C203 ECL2 R mutation disrupts the disulfide bond linkage between C203 ECL2 and C126 3.25 , which is also observed in MWS-opsin (Figure 6B).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…In this study, we collected some mutations associated with color vision deficiencies (Figure 6 and Figure S8). The mutations identified within the LWS-opsin are K82 ICL1 E, N94 2.45 K, V120 ECL1 M, S143 3.42 P, W177 4.50 R, C203 ECL2 R, P231 5.50 L, R247 5.66 X, P307 7.38 L, R330 8.51 Q, and G338 8.59 E(Nathans et al, 1993; Ueyama et al, 2002; Carroll et al, 2004; Ueyama et al, 2004; Mizrahi-Meissonnier et al, 2010; Cai et al, 2019; Iarossi et al, 2021; Zhu et al, 2021) (Figures 6A and S8A). It is noteworthy that the C203 ECL2 R mutation disrupts the disulfide bond linkage between C203 ECL2 and C126 3.25 , which is also observed in MWS-opsin (Figure 6B).…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies have reported that missense mutations in cone opsins associated with color vision deficiencies, however, the specific mechanisms remain unclear. (Weitz et al, 1992; Nathans et al, 1993; Ueyama et al, 2002; Carroll et al, 2004; Ueyama et al, 2004; Neitz et al, 2004; Mizrahi-Meissonnier et al, 2010; Cai et al, 2019; Neitz et al, 2020; Iarossi et al, 2021; Zhu et al, 2021). Our findings also provide some molecular insights from the structural perspective to color vision deficiencies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…AMD is a common macular disease affecting elderly people, which ranks third as a cause of blindness after cataract and glaucoma. 13 At present, there is no effective treatment methods. The biggest obstacle to developing treatments is the lack of understanding of the molecular basis of disease.…”
Section: Discussionmentioning
confidence: 99%
“…In a previous study, we used an AAV-based gene delivery approach to investigate the in vivo expression pattern and pathobiology of five cone opsin missense mutations (N94K, W177R, P307L, R330Q, and G338E) after expression in M-opsin knockout ( Opn1mw −/− ) mice ( Zhu et al, 2021 ). In this study, we characterize the disease mechanisms of three additional cone opsin missense mutants that have been shown to cause color-vison deficiency or BCM ( Neitz et al, 2004 ; Katagiri et al, 2018 ; Cai et al, 2019 ). We expressed OPN1LW cone opsin mutants K82E, P187S, and M273K specifically in Opn1mw −/− and WT cones using a cone-specific PR2.1 promoter ( Mancuso et al, 2009 ).…”
Section: Introductionmentioning
confidence: 99%